Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Rihácek

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Vnitrni Lekarstvi|March 23, 2011
[Chronic thromboembolic pulmonary hypertension]I Rihácek
Vnitrni Lekarstvi|June 1, 1993
[Primary pulmonary hypertension]I Rihácek, M Soucek, J Toman
Vnitrni Lekarstvi|May 3, 2007
[The smoothness index of betaxolol hydrochloride in patients with newly diagnosed hypertension]I Rihácek, M Soucek, P Frána
Vnitrni Lekarstvi|September 1, 1995
[Betaxolol hydrochloride in the treatment of mild and medium hypertension--long-term effects]M Soucek, J Julínek, I Rihácek, et al.
Vnitrni Lekarstvi|October 1, 2011
[The importance of antihypertensive therapy in subclinical brain damage]M Soucek, I Rihácek, P Frána, et al.
Vnitrni Lekarstvi|December 9, 2010
[Our experience with endoscopic drainage of pancreatic pseudocysts]B Kianicka, I Novotný, M Soucek, et al.
Vnitrni Lekarstvi|September 18, 2010
[Aortic pulse wave velocity in patients with metabolic syndrome and hypertension treated with sartans]J Spác, M Soucek, I Rihácek, et al.
Vnitrni Lekarstvi|August 5, 2010
[The normalized smoothness index and parametric population RDH index of telmisartane in patients with newly diagnosed hypertension and metabolic syndrome]I Rihácek, P Frána, D Schwarz, et al.
Vnitrni Lekarstvi|July 24, 2007
[Increased activity of the sympathetic nervous system and the possibilities for therapeutic influence]M Soucek, J Nevrlka, I Rihácek, et al.
Vnitrni Lekarstvi|April 8, 2009
[The diurnal variability of blood pressure in patients with hypertension and rheumatoid arthritis]I Rihácek, P Frána, M Soucek, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Vnitrni Lekarstvi|March 23, 2011
[Chronic thromboembolic pulmonary hypertension]I Rihácek
Vnitrni Lekarstvi|June 1, 1993
[Primary pulmonary hypertension]I Rihácek, M Soucek, J Toman
Vnitrni Lekarstvi|May 3, 2007
[The smoothness index of betaxolol hydrochloride in patients with newly diagnosed hypertension]I Rihácek, M Soucek, P Frána
Vnitrni Lekarstvi|September 1, 1995
[Betaxolol hydrochloride in the treatment of mild and medium hypertension--long-term effects]M Soucek, J Julínek, I Rihácek, et al.
Vnitrni Lekarstvi|October 1, 2011
[The importance of antihypertensive therapy in subclinical brain damage]M Soucek, I Rihácek, P Frána, et al.
Vnitrni Lekarstvi|December 9, 2010
[Our experience with endoscopic drainage of pancreatic pseudocysts]B Kianicka, I Novotný, M Soucek, et al.
Vnitrni Lekarstvi|September 18, 2010
[Aortic pulse wave velocity in patients with metabolic syndrome and hypertension treated with sartans]J Spác, M Soucek, I Rihácek, et al.
Vnitrni Lekarstvi|August 5, 2010
[The normalized smoothness index and parametric population RDH index of telmisartane in patients with newly diagnosed hypertension and metabolic syndrome]I Rihácek, P Frána, D Schwarz, et al.
Vnitrni Lekarstvi|July 24, 2007
[Increased activity of the sympathetic nervous system and the possibilities for therapeutic influence]M Soucek, J Nevrlka, I Rihácek, et al.
Vnitrni Lekarstvi|April 8, 2009
[The diurnal variability of blood pressure in patients with hypertension and rheumatoid arthritis]I Rihácek, P Frána, M Soucek, et al.
Pageof 2